Article
Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: clinical and genotypic predictors of virologic response.
Journal of acquired immune deficiency syndromes (1999) - 1 Mar 2000
Shulman N S, Zolopa A R, Passaro D J, Murlidharan U, Israelski D M, Brosgart C L, Miller M D, Van Doren S, Shafer R W, Katzenstein D A
Abstract excerpt
OBJECTIVE: To determine the impact of prior nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy, genotypic resistance, and other variables on response to efavirenz (EFV)- and adefovir dipivoxil (ADV)-based salvage therapy. DESIGN: Retrospective clinical cohort study. SETTING: One university and one community-based HIV clinic. STUDY SUBJECTS: All 33 patients who were coenrolled in both the EFV and ADV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.